États-Unis · Plateformes & données · Stocktwits

IBRX Stock Rises Overnight: Jim Cramer Backs ImmunityBio As A ‘Very Good Spec’ Amid Biotech Takeover Wave

Publié par Stocktwits · États-Unis il y a 12 h

ImmunityBio (IBRX) shares rose nearly 1% overnight heading into Tuesday after CNBC host Jim Cramer called it a “very good spec,” citing a wave of biotech acquisitions as the…

Lire l'article complet sur Stocktwits Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stocktwits.com)

IBRX Stock Rises Overnight: Jim Cramer Backs ImmunityBio As A ‘Very Good Spec’ Amid Biotech Takeover Wave

À lire aussi

Watsco GAAP EPS of $3.77 misses by $0.32, revenue of $2.22B beats by $10M

AI debt trouble could help Fed’s Warsh get his way with fewer rate hikes

Spotify Technology (NYSE:SPOT) Cut to "Moderate Buy" at Phillip Securities

Breakfast News: Delivery King Eyes Grocery Carts

Best Stocks Under $5

BTIG raises CareDx stock price target to $81 on revenue outlook

IBRX Stock Rises Overnight: Jim Cramer Backs ImmunityBio As A ‘Very Good Spec’ Amid Biotech Takeover Wave

Partager

À lire aussi

Watsco GAAP EPS of $3.77 misses by $0.32, revenue of $2.22B beats by $10M

AI debt trouble could help Fed’s Warsh get his way with fewer rate hikes

Spotify Technology (NYSE:SPOT) Cut to "Moderate Buy" at Phillip Securities

Breakfast News: Delivery King Eyes Grocery Carts

Best Stocks Under $5

BTIG raises CareDx stock price target to $81 on revenue outlook